Compare SPIR & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPIR | NPCE |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 698.8M | 623.0M |
| IPO Year | 2020 | 2021 |
| Metric | SPIR | NPCE |
|---|---|---|
| Price | $18.92 | $15.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $16.40 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 1.6M | 196.7K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 134.98 | 29.03 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $110,451,000.00 | $99,986,000.00 |
| Revenue This Year | $12.31 | $0.90 |
| Revenue Next Year | $22.63 | $24.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 13.15 | ★ 25.13 |
| 52 Week Low | $6.60 | $7.56 |
| 52 Week High | $23.59 | $19.60 |
| Indicator | SPIR | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 56.14 | 43.95 |
| Support Level | $7.88 | $15.17 |
| Resistance Level | $23.59 | $17.04 |
| Average True Range (ATR) | 1.65 | 1.14 |
| MACD | -0.05 | -0.31 |
| Stochastic Oscillator | 80.48 | 30.76 |
Spire Global Inc provides space-based data, analytics, and space services, offering datasets and insights about Earth to support decision-making. It builds, owns, and operates a constellation of nanosatellites that observe the Earth in real time using radio frequency (RF) technology. Additionally, it offers Space Services solutions that allow customers to deploy and scale their own satellite constellations using its platform, ground station network, manufacturing facilities, and launch partnerships. The company derives revenue from providing data, insights and access to its cloud-based technology platform sold on a subscription basis.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.